Cefpodoxime Tablets   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) and the Department of Defense (DoD) Pharmaceutical Prime Vendor Program. The purpose of this solicitation is to establish a supply source that will provide drugs listed in the schedule for purchase through the PPV Programs. The total annual estimated usage for VA, Federal Health Care Center (FHCC), State Veterans Homes - Option 2 (SVH), DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP) appears on the Schedule of Supplies section of this Solicitation.

Work Details
The specific product to be manufactured or delivered under the contract is Cefpodoxime Proxetil Tablets. The contract requires one award to be made in the aggregate for line items 1 and 2. Offerors must submit a price for the base year and all four one-year options for all line items. Prices offered shall not exceed two decimal places. Offered prices must include an 11 digit NDC number for each offered drug that is unique to the Offeror's company as outlined in scope of contract.

Period of Performance
The Implementation Period will begin on the Contract Effective Date and end at the start of the Ordering Period, which will be in effect for one year. The Ordering Period begins at the expiration of the Implementation Period.

Place of Performance
The products will be delivered to various facilities including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DoD) Pharmaceutical Prime Vendor Program, all Indian Health Service (IHS) facilities, all Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.